grant

Gynecologic cancer care: Improving clinical trial enrollment through molecular matching with targeted therapies and improving access to care and research

Organization OHIO STATE UNIVERSITYLocation Columbus, UNITED STATESPosted 11 Sept 2024Deadline 31 Aug 2029
NIHUS FederalResearch GrantFY2025Access to CareAdvisory CommitteesAreaAwardAwarenessBody of uterusBrachytherapyCancer PatientCancersClinical TrialsCollaborationsComprehensive Cancer CenterCorpus UteriCurietherapyDNA mutationDevelopmentDevelopmental TherapeuticsDevelopmental Therapeutics ProgramDevelopmental TherapyDiseaseDisorderDoctor of PhilosophyDrug CommitteeEndometrial CancerEndometrial CarcinomaEndometrium CancerEndometrium CarcinomaEnrollmentEpidemiologyExposure toFailureFellowshipFemale Reproductive CancerFloorFormulary CommitteeFundingGenetic ChangeGenetic defectGenetic mutationGoalsGynecologic CancerGynecologic OncologyGynecological CancerHealth Services AccessibilityImmune mediated therapyImmunologically Directed TherapyImmunotherapyImprove AccessIncidenceInstitutionInterdisciplinary ResearchInterdisciplinary StudyInvestigatorsMMR deficiencyMalignant Female Reproductive System NeoplasmMalignant Gynecologic NeoplasmMalignant Gynecologic TumorMalignant Neoplasm of the UterusMalignant NeoplasmsMalignant TumorMalignant Tumor of the Female Reproductive SystemMalignant Tumor of the UterusMalignant Uterine NeoplasmMalignant Uterine TumorMentorsMismatch Repair DeficiencyMolecularMolecular FingerprintingMolecular ProfilingMultidisciplinary CollaborationMultidisciplinary ResearchMutationNational Clinical Trials NetworkOhioOncologyOncology CancerPatient outcomePatient-Centered OutcomesPatient-Focused OutcomesPatientsPh.D.PhDPharmacy CommitteesPopulationPrevention trialProcessRadiation BrachytherapyRadioisotope BrachytherapyResearchResearch PersonnelResearch ResourcesResearchersResourcesRiskRoleSiteSystemTask ForcesTherapeutics CommitteeTimeToxic effectToxicitiesUniversitiesUterine BodyUterine CancerUterusUterus CancerVaginaWorkaccess to health servicesaccess to servicesaccess to treatmentaccessibility to health servicesadvisory teamavailability of servicescancer carecancer locationcancer sitecancer sub-typescancer subtypescancers that are rarecare accessclinical trial enrollmentcontrol trialdesigndesigningdevelopmentalenrollepidemiologicepidemiologicalethnic minorityexpression subtypesgenome mutationgynecologic malignancygynecological malignancyhealth service accesshealth services availabilityhigh riskimmune therapeutic approachimmune therapeutic interventionsimmune therapeutic regimensimmune therapeutic strategyimmune therapyimmune-based therapiesimmune-based treatmentsimmuno therapyimprovedimproved outcomeineffective therapiesineffective treatmentmalignancymembermolecular profilemolecular signaturemolecular sub-typesmolecular subsetsmolecular subtypesmortalityneoplasm/cancernovelpatient oriented outcomespersonalization of treatmentpersonalized medicinepersonalized therapypersonalized treatmentracial minorityrare cancerrare malignancyrare tumorservice availabilitysocial roletargeted drug therapytargeted drug treatmentstargeted therapeutictargeted therapeutic agentstargeted therapytargeted treatmenttreatment accesstreatment trialwomb
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Gynecologic Cancer remains an underfunded area of research with funding to lethality scores significantly lower than other cancer sites. Endometrial cancer, the most common gynecologic cancer, is one of the few cancers that has seen an increase in incidence and mortality over the recent years.. High risk and rare subtypes of uterine cancers have…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Gynecologic cancer care: Improving clinical trial enrollment through molecular matching with targeted therapies and impr | Dev Procure